{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:13:15Z","timestamp":1775484795480,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015807","name":"Hangzhou Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["No. B20220384"],"award-info":[{"award-number":["No. B20220384"]}],"id":[{"id":"10.13039\/100015807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["Nos. 2019RC253, 2019KY537"],"award-info":[{"award-number":["Nos. 2019RC253, 2019KY537"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sirtuin 1, a class III histone deacetylase, plays a critical role in the pathophysiology of both diabetes mellitus and bone metabolism by promoting osteoblast differentiation and inhibiting osteoclast maturation. However, its exact impact on bone mineral density (BMD) and bone metabolism in type 2 diabetes mellitus (T2DM) remains unclear. This study investigates the relationship between Sirtuin 1 levels, BMD, and bone metabolism in newly diagnosed T2DM patients, specifically examining alterations in Sirtuin 1 levels in those with concomitant osteoporosis or osteopenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 69 newly diagnosed T2DM patients and 82 control subjects with normal glucose tolerance (NGT) were enrolled. Serum Sirtuin 1 levels and bone turnover markers, including osteocalcin (OC), procollagen type 1 N-terminal propeptide (P1NP), and \u03b2-C-terminal telopeptide of type I collagen (\u03b2-CTX), were measured using enzyme-linked immunosorbent assay (ELISA). BMD was assessed via dual-energy X-ray absorptiometry (DXA). Comparisons of these parameters were made between the T2DM and NGT groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>T2DM patients were further categorized into a normal BMD group (DMn) and an osteopenia or osteoporosis group (DMo), and differences in Sirtuin 1 levels between these subgroups were analyzed. Risk factors for osteoporosis\/osteopenia in T2DM patients were also evaluated. Serum Sirtuin 1 levels were found to be significantly diminished in the T2DM group relative to the control group (P &amp;lt; 0.05), with no significant differences in lumbar spine BMD, OC, 25(OH)D, and \u03b2-CTX between groups (P &amp;gt; 0.05). Osteoporosis incidence was higher in T2DM subjects compared to controls (34.8% vs. 18.3%, P = 0.026). Subgroup analysis revealed that SIRT1 levels in T2DM patients with osteoporosis or osteopenia exhibited a significant reduction compared to those with normal BMD (P &amp;lt; 0.05). Logistic regression indicated that Sirtuin 1, age, HDL-C, P1NP, and \u03b2-CTX were independent risk factors for osteoporosis in T2DM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In conclusion, decreased serum Sirtuin 1 levels are associated with bone turnover markers in T2DM patients and may serve as an independent risk factor and potential biomarker for diagnosing bone metabolism disorders in newly diagnosed T2DM patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1480847","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:23:41Z","timestamp":1738128221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased sirtuin 1 in type 2 diabetes patients with abnormal BMD"],"prefix":"10.3389","volume":"15","author":[{"given":"Yao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2022.02.006","article-title":"Assessment and treatment of osteoporosis and fractures in type 2 diabetes","volume":"33","author":"Sheu","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.xcrm.2024.101694","article-title":"Advanced glycation end products mediate biomineralization disorder in diabetic bone disease","volume":"5","author":"Gao","year":"2024","journal-title":"Cell Rep Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.727132","article-title":"Vitamin D status is negatively related to insulin resistance and bone turnover in Chinese non-osteoporosis patients with type 2 diabetes: A retrospective cross-section research","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145169","article-title":"Osteocyte-related cytokines regulate osteoclast formation and bone resorption","volume":"21","author":"Kitaura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2014.5944","article-title":"Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes","volume":"21","author":"Mangialardi","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4140","article-title":"Bone turnover markers do not predict fracture risk in type 2 diabetes","volume":"35","author":"Napoli","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.589016","article-title":"The versatility of sirtuin-1 in endocrinology and immunology","volume":"8","author":"Rasha","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00187","article-title":"Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function","volume":"10","author":"Kitada","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae100","article-title":"Inhibition of de novo ceramide synthesis by Sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes","volume":"120","author":"Velagapudi","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.04.017","article-title":"Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition","volume":"19","author":"Zhang","year":"2023","journal-title":"Bioact Mater"},{"key":"B11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/ijbs.78654","article-title":"Novel role of the SIRT1 in endocrine and metabolic diseases","volume":"19","author":"Lu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194748","article-title":"Proposed tandem effect of physical activity and sirtuin 1 and 3 activation in regulating glucose homeostasis","volume":"20","author":"Pacifici","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779177","article-title":"SIRT1: A potential therapeutic target in autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_6035","article-title":"Circ-Sirt1 promotes osteoblast differentiation by activating Sirt1 and Wnt\/\u03b2-catenin pathway","volume":"70","author":"Li","year":"2023","journal-title":"Acta Biochim Pol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13596","article-title":"SIRT1 activation promotes bone repair by enhancing the coupling of type H vessel formation and osteogenesis","volume":"57","author":"Liu","year":"2024","journal-title":"Cell Prolif"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/biom14080970","article-title":"Sirt1: an increasingly interesting molecule with a potential role in bone metabolism and osteoporosis","volume":"14","author":"Chen","year":"2024","journal-title":"Biomolecules"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.04.005","article-title":"Low blood and vitreal BDNF, LXA4 and altered Th1\/Th2 cytokine balance are potential risk factors for diabetic retinopathy","volume":"64","author":"Kaviarasan","year":"2015","journal-title":"Metabolism"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ph13060130","article-title":"Differential expression of kinin receptors in human wet and dry age-related macular degeneration retinae","volume":"13","author":"Othman","year":"2020","journal-title":"Pharm (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1641717","DOI":"10.1155\/2021\/1641717","article-title":"ALDH2\/SIRT1 contributes to type 1 and type 2 diabetes-induced retinopathy through depressing oxidative stress","volume":"2021","author":"He","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad740","article-title":"SIRT1 and miR-34a-5p: valuable biomarkers for the early detection of cognitive impairment in type 2 diabetes mellitus","volume":"109","author":"Vezza","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13098-021-00736-2","article-title":"Klotho and SIRT1 changes from pre-diabetes to diabetes and pre-hypertension to hypertension","volume":"13","author":"Yeganeh-Hajahmadi","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.v105:6","article-title":"HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death","volume":"105","author":"Brodeur","year":"2008","journal-title":"J Cell Biochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0292-0","article-title":"Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women","volume":"48","author":"Yamauchi","year":"2015","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190873","article-title":"Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL","volume":"133","author":"Hui","year":"2019","journal-title":"Clin Sci (Lond)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1480847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:23:47Z","timestamp":1738128227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1480847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":25,"alternative-id":["10.3389\/fendo.2024.1480847"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1480847","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"article-number":"1480847"}}